Physician
Eastern Shore Pediatrics
Eastern Shore Pediatrics was paid $2.98M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoEASTERN SHORE PEDIATRICS
SALISBURY, MD 21801
SALISBURY, MD 21801
33aNPI1063713295assigned 11/04/2010
33bProvider typePediatrics Physician
28Total paid$2.98M
24GClaims78,929
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#39 of 306
Median peer was paid$206K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 720 | $16K | |
| 2019 | 689 | $15K | |
| 2020 | 16,103 | $518K | |
| 2021 | 16,312 | $575K | |
| 2022 | 16,012 | $678K | |
| 2023 | 14,426 | $573K | |
| 2024incomplete | 14,667 | $602K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 6,462 | 5,666 | $750K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 6,216 | 5,510 | $504K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.7% | 2,147 | 2,090 | $231K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.6% | 2,115 | 2,043 | $226K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.5% | 2,489 | 1,852 | $223K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.4% | 1,617 | 1,570 | $192K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.2% | 1,005 | 918 | $156K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.5% | 2,610 | 2,331 | $103K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.0% | 9,966 | 8,333 | $89K |
| D1206 | Topical application of fluoride varnish | 2.4% | 2,932 | 2,888 | $73K |
| 90658 | 1.5% | 2,004 | 1,928 | $45K | |
| 92551 | 1.3% | 4,158 | 4,008 | $39K |
41 more codes
| 90733 | 1.2% | 445 | $35K | |
| 90670 | 1.1% | 1,498 | $33K | |
| 96127 | 1.0% | 6,407 | $30K | |
| 90647 | <1% | 1,402 | $30K | |
| 90723 | <1% | 1,163 | $25K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,282 | $25K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 558 | $23K |
| 90680 | <1% | 1,000 | $22K | |
| 90633 | <1% | 815 | $18K | |
| 90710 | <1% | 658 | $15K | |
| 81002 | <1% | 4,649 | $12K | |
| 90657 | <1% | 526 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 977 | $12K |
| 99173 | <1% | 4,559 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 952 | $9K |
| 90650 | <1% | 482 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 117 | $6K |
| 96161 | <1% | 2,509 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,059 | $3K |
| 0002A | <1% | 80 | $2K | |
| 90700 | <1% | 85 | $2K | |
| 0001A | <1% | 84 | $2K | |
| 90715 | <1% | 75 | $2K | |
| 99177 | <1% | 316 | $2K | |
| 90696 | <1% | 66 | $2K | |
| 90620 | <1% | 65 | $1K | |
| 0071A | <1% | 34 | $1K | |
| 0072A | <1% | 34 | $1K | |
| 99050 | <1% | 44 | $783.60 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 45 | $500.00 |
| 99422 | <1% | 2,025 | $495.00 | |
| 99070 | <1% | 710 | $480.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $352.52 |
| 90649 | <1% | 12 | $256.08 | |
| 90381 | <1% | 19 | $209.51 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 13 | $90.68 |
| 87400 | <1% | 12 | $84.75 | |
| 3074F | 0% | 50 | $0.00 | |
| 91307 | 0% | 99 | $0.00 | |
| 91300 | 0% | 218 | $0.00 | |
| 3078F | 0% | 51 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANIEL, EPHREM (OWNER/PRESIDENT)